Intrinsic Value
Corvus Pharmaceuticals, Inc. (CRVS)
$1.46
-0.02 (-1.35%)
| Enterprise Value | - |
|---|---|
| Net Debt | -11.25 |
| Equity Value | - |
| Shares Outstanding | 48.03 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt